Australia's Sigma Eyes Bid for Symbion (Australia)
This article was originally published in PharmAsia News
Executive Summary
Sigma Pharmaceuticals of Australia plans to join the fray and make a bid to purchase Symbion Health's large network of pharmacy services and consumer pharmaceutical businesses in Australia. Healthscope and its partners already have bid 2.86 billion Australian dollars for it. Sigma's interest may derail that deal. (Click here for more